p38α has multi-functional mechanisms of action. This has enabled GEn1E to build its unique AI/ML-based technology platform creating a beachhead in inflammatory diseases, which currently do not have effective treatment. Our Machine Learning models that trained using this data span the entire process chain from drug discovery to clinical trials. This enables us to accelerate the drug development cycle, create cost efficiencies and take multiple shots at the goal.